Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 183

1.

Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin.

Nourse J, Firpo E, Flanagan WM, Coats S, Polyak K, Lee MH, Massague J, Crabtree GR, Roberts JM.

Nature. 1994 Dec 8;372(6506):570-3.

PMID:
7990932
2.

Limiting amounts of p27Kip1 correlates with constitutive activation of cyclin E-CDK2 complex in HTLV-I-transformed T-cells.

Cereseto A, Washington Parks R, Rivadeneira E, Franchini G.

Oncogene. 1999 Apr 15;18(15):2441-50.

3.

TGF-beta 1 induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells.

Kamesaki H, Nishizawa K, Michaud GY, Cossman J, Kiyono T.

J Immunol. 1998 Jan 15;160(2):770-7.

4.
5.

Cyclin E-CDK2 is a regulator of p27Kip1.

Sheaff RJ, Groudine M, Gordon M, Roberts JM, Clurman BE.

Genes Dev. 1997 Jun 1;11(11):1464-78.

6.

Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta.

Reynisdóttir I, Polyak K, Iavarone A, Massagué J.

Genes Dev. 1995 Aug 1;9(15):1831-45.

7.

Mechanism of action of the immunosuppressant rapamycin.

Dumont FJ, Su Q.

Life Sci. 1996;58(5):373-95. Review.

PMID:
8594303
8.

Involvement of p21 and p27 in the regulation of CDK activity and cell cycle progression in the regenerating liver.

Albrecht JH, Poon RY, Ahonen CL, Rieland BM, Deng C, Crary GS.

Oncogene. 1998 Apr 23;16(16):2141-50.

9.

The upregulation of p27Kip1 by rapamycin results in G1 arrest in exponentially growing T-cell lines.

Kawamata S, Sakaida H, Hori T, Maeda M, Uchiyama T.

Blood. 1998 Jan 15;91(2):561-9.

10.
11.

Formation of p27-CDK complexes during the human mitotic cell cycle.

Soos TJ, Kiyokawa H, Yan JS, Rubin MS, Giordano A, DeBlasio A, Bottega S, Wong B, Mendelsohn J, Koff A.

Cell Growth Differ. 1996 Feb;7(2):135-46.

12.

Rapamycin inhibition of interleukin-2-dependent p33cdk2 and p34cdc2 kinase activation in T lymphocytes.

Morice WG, Wiederrecht G, Brunn GJ, Siekierka JJ, Abraham RT.

J Biol Chem. 1993 Oct 25;268(30):22737-45.

13.

Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase.

Hsieh FF, Barnett LA, Green WF, Freedman K, Matushansky I, Skoultchi AI, Kelley LL.

Blood. 2000 Oct 15;96(8):2746-54.

14.

p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21.

Toyoshima H, Hunter T.

Cell. 1994 Jul 15;78(1):67-74.

PMID:
8033213
15.
16.

A new pathway for mitogen-dependent cdk2 regulation uncovered in p27(Kip1)-deficient cells.

Coats S, Whyte P, Fero ML, Lacy S, Chung G, Randel E, Firpo E, Roberts JM.

Curr Biol. 1999 Feb 25;9(4):163-73.

18.

Growth arrest by the cyclin-dependent kinase inhibitor p27Kip1 is abrogated by c-Myc.

Vlach J, Hennecke S, Alevizopoulos K, Conti D, Amati B.

EMBO J. 1996 Dec 2;15(23):6595-604.

19.

Supplemental Content

Support Center